S&P cuts Lantheus Medical

Standard & Poor's said it lowered its corporate credit rating on Lantheus Medical Imaging Inc. to B- from B. The outlook is negative.

Commensurate with the downgrade, S&P lowered the issue-level rating on Lantheus' senior unsecured notes to B- from B. The recovery rating on the notes is unchanged at 4, indicating an expectation for average (30%-50%) recovery in the event of payment default.

The downgrade follows EBITDA generation that has been weaker than S&P expected, resulting in higher leverage and pressuring liquidity, the agency said.

"The ratings on Lantheus reflect a 'vulnerable' business risk profile characterized by small size and scale that makes it particularly susceptible to customer pricing demands, a dependence on third-party contract manufacturers, product concentration, and a narrow business focus," said S&P credit analyst Michael Berrian in a news release. "We still view Lantheus' financial risk profile as 'highly leveraged,' but it is weaker in the category than previously."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.